StockNews.com initiated protection on shares of OncoSec Skilled medical (NASDAQ:ONCS – Get Rating) in a report launched on Monday. The brokerage set a “promote” rating on the biotechnology firm’s stock.
Individually, BTIG Examine minimized their think about value on OncoSec Scientific from $10.00 to $5.00 and established a “purchase” score on the stock in a report on Wednesday, March sixteenth.
ONCS stock opened at $1.06 on Monday. OncoSec Healthcare has a 1-yr small of $.75 and a 1-calendar yr superior of $5.55. The group has a market cap of $41.71 million, a P/E ratio of -1.02 and a beta of 1.99. The enterprise’s 50 working day relocating bizarre is $1.01 and its 200-day transferring typical is $1.27.
OncoSec Medical (NASDAQ:ONCS – Get Score) final launched its quarterly earnings knowledge on Tuesday, March fifteenth. The biotechnology company documented ($.25) earnings for each share for the quarter, missing the consensus estimate of ($.11) by ($.14). On typical, research analysts hope that OncoSec Medical will publish -.59 earnings per share for the latest fiscal yr.
Massive patrons haven’t too way back bought and purchased shares of the enterprise. Level out Avenue Corp acquired a brand new place in OncoSec Skilled medical throughout the 2nd quarter actually value $56,000. HighTower Advisors LLC obtained a brand new state of affairs in OncoSec Medical all by means of the third quarter actually value $45,000. Goldman Sachs Group Inc. acquired a brand new place in shares of OncoSec Medical within the third quarter valued at $53,000. Susquehanna Worldwide Group LLP lifted its stake in shares of OncoSec Skilled medical by 62.7% within the 4th quarter. Susquehanna Worldwide Group LLP now owns 44,075 shares of the biotechnology firm’s stock valued at $42,000 quickly after buying an extra 16,990 shares in the middle of the interval. Ultimately, Tocqueville Asset Administration L.P. lifted its stake in shares of OncoSec Scientific by 86.8% within the third quarter. Tocqueville Asset Administration L.P. now owns 49,500 shares of the biotechnology firm’s inventory valued at $105,000 instantly after buying an additional 23,000 shares through the time interval. 16.39% of the inventory is in the meanwhile owned by hedge assets and different institutional buyers.
OncoSec Well being-related Enterprise Profile (Get Rating)
OncoSec Skilled medical, Inc is a biotechnology agency focused on constructing, creating and commercializing therapies and proprietary health-related strategies to encourage and to guideline an anti-tumor immune response for the remedy methodology of most cancers. Its information product prospect, ImmunoPulse IL-12, makes use of an electroporation product, with the aim of reversing the immunosuppressive microenvironment within the taken care of tumor.
Need Way more Glorious Investing Concepts?
Get Information & Rankings for OncoSec Skilled medical Day-to-day – Enter your e mail handle down under to get a concise day-to-day abstract of the most well liked info and analysts’ scores for OncoSec Well being-related and related companies with MarketBeat.com’s Freed from cost daily piece of email e-newsletter.